The role of surgery in integrated therapies for non-small-cell lung cancer

F. Sartori, L. Bortolotti, M. Michelon, F. Colaut, M. Loy, F. Rea, A. Favaretto

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Surgery represents the best treatment for early-stage non-small-cell lung cancer (NSCLC). In selected cases, even locally-advanced cancers may be suitable for surgical treatment. The combination of chemotherapy (with or without radiotherapy) and surgery has proved potentially useful in improving survival, but pre-operative treatment may represent a risk factor for the onset of post-operative complications. Studies performed to date indicate the need for further multidisciplinary research with a view to identifying more advantageous treatment modalities, particularly for locally-advanced NSCLC.

Original languageEnglish
JournalAnnals of Oncology
Volume10
Issue numberSUPPL. 5
Publication statusPublished - 1999

Fingerprint

Non-Small Cell Lung Carcinoma
Therapeutics
Combination Drug Therapy
Radiotherapy
Research
Neoplasms

Keywords

  • Combined modalities
  • Non-small-lung cancer
  • Surgery

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Sartori, F., Bortolotti, L., Michelon, M., Colaut, F., Loy, M., Rea, F., & Favaretto, A. (1999). The role of surgery in integrated therapies for non-small-cell lung cancer. Annals of Oncology, 10(SUPPL. 5).

The role of surgery in integrated therapies for non-small-cell lung cancer. / Sartori, F.; Bortolotti, L.; Michelon, M.; Colaut, F.; Loy, M.; Rea, F.; Favaretto, A.

In: Annals of Oncology, Vol. 10, No. SUPPL. 5, 1999.

Research output: Contribution to journalArticle

Sartori, F, Bortolotti, L, Michelon, M, Colaut, F, Loy, M, Rea, F & Favaretto, A 1999, 'The role of surgery in integrated therapies for non-small-cell lung cancer', Annals of Oncology, vol. 10, no. SUPPL. 5.
Sartori F, Bortolotti L, Michelon M, Colaut F, Loy M, Rea F et al. The role of surgery in integrated therapies for non-small-cell lung cancer. Annals of Oncology. 1999;10(SUPPL. 5).
Sartori, F. ; Bortolotti, L. ; Michelon, M. ; Colaut, F. ; Loy, M. ; Rea, F. ; Favaretto, A. / The role of surgery in integrated therapies for non-small-cell lung cancer. In: Annals of Oncology. 1999 ; Vol. 10, No. SUPPL. 5.
@article{2a138d8a62e44a40bccef2c711d80459,
title = "The role of surgery in integrated therapies for non-small-cell lung cancer",
abstract = "Surgery represents the best treatment for early-stage non-small-cell lung cancer (NSCLC). In selected cases, even locally-advanced cancers may be suitable for surgical treatment. The combination of chemotherapy (with or without radiotherapy) and surgery has proved potentially useful in improving survival, but pre-operative treatment may represent a risk factor for the onset of post-operative complications. Studies performed to date indicate the need for further multidisciplinary research with a view to identifying more advantageous treatment modalities, particularly for locally-advanced NSCLC.",
keywords = "Combined modalities, Non-small-lung cancer, Surgery",
author = "F. Sartori and L. Bortolotti and M. Michelon and F. Colaut and M. Loy and F. Rea and A. Favaretto",
year = "1999",
language = "English",
volume = "10",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "SUPPL. 5",

}

TY - JOUR

T1 - The role of surgery in integrated therapies for non-small-cell lung cancer

AU - Sartori, F.

AU - Bortolotti, L.

AU - Michelon, M.

AU - Colaut, F.

AU - Loy, M.

AU - Rea, F.

AU - Favaretto, A.

PY - 1999

Y1 - 1999

N2 - Surgery represents the best treatment for early-stage non-small-cell lung cancer (NSCLC). In selected cases, even locally-advanced cancers may be suitable for surgical treatment. The combination of chemotherapy (with or without radiotherapy) and surgery has proved potentially useful in improving survival, but pre-operative treatment may represent a risk factor for the onset of post-operative complications. Studies performed to date indicate the need for further multidisciplinary research with a view to identifying more advantageous treatment modalities, particularly for locally-advanced NSCLC.

AB - Surgery represents the best treatment for early-stage non-small-cell lung cancer (NSCLC). In selected cases, even locally-advanced cancers may be suitable for surgical treatment. The combination of chemotherapy (with or without radiotherapy) and surgery has proved potentially useful in improving survival, but pre-operative treatment may represent a risk factor for the onset of post-operative complications. Studies performed to date indicate the need for further multidisciplinary research with a view to identifying more advantageous treatment modalities, particularly for locally-advanced NSCLC.

KW - Combined modalities

KW - Non-small-lung cancer

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=0032717242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032717242&partnerID=8YFLogxK

M3 - Article

C2 - 10582144

AN - SCOPUS:0032717242

VL - 10

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - SUPPL. 5

ER -